INOZYME PHARMA INC. -
5,2100
07-октября-24 14:59:31
15 мин. задержка
Акции
+0,0400
+0,77%
Сегодняшний диапазон
5,1200 - 5,2800
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Inozyme Pharma to Participate in Upcoming Investor Conferences
09 ноя 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
07 ноя 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 ноя 2023 15:15:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Announces Presentation at the American Society of Nephrology (ASN) Kidney Week 2023
26 окт 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
10 окт 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
06 окт 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
26 сен 2023 06:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma to Host Virtual Investor and Analyst Event on Sep. 26, 2023
20 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference
05 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights
08 авг 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 авг 2023 15:01:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma, Inc. Announces Closing of Public Offering of Common Stock
01 авг 2023 15:01:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock
27 июл 2023 22:20:15 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma, Inc. Announces Proposed Offering of Common Stock
27 июл 2023 15:33:08 Источник Nasdaq GlobeNewswire
-
26 июл 2023 06:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma to Provide ENPP1 Deficiency Program Update on July 26, 2023
19 июл 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Announces Dosing of First Infant with ENPP1 Deficiency in a Phase 1b Trial of INZ-701
27 июн 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at the Jefferies Healthcare Conference
02 июн 2023 06:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Reports First Quarter 2023 Financial Results and Provides Business Highlights
09 май 2023 07:30:00 Источник Nasdaq GlobeNewswire